About Caroline Loew
Caroline Loew is a president & CEO, solstice oncology, director at Solstice Oncology.
Experience
This experience comes from Caroline Loew's profile and from SEC filings. For roles taken from filings, the years are when the filings name Caroline Loew in the role, so the role may have started earlier or lasted longer.
Solstice Oncology, Inc. Current
President & CEO, Solstice Oncology, director
2026 – Present · Boston, MA
Develops cancer immunotherapy for patients before surgery, beginning with colon cancer.
RM
RA Capital Management
Venture Partner
2025 – 2026
MO
Mural Oncology
CEO
2023 – 2025
GB
Glympse Bio
Strategic Advisor | Consultant
2018 – 2022
BS
Bristol-Myers Squibb
Vice President, Head of R&D Strategy and Planning
2015 – 2018
ME
Merck
Vice President, Late Lifecycle Management and Loss of Exclusivity Center of Excellence
2007 – 2015
PH
PhRMA
Senior Vice President
1999 – 2007
Key Colleagues at Startups
The people Caroline Loew works with at each company, as listed on that company's latest Form D.
Solstice Oncology, Inc. · Form D, Mar 9, 2026
David Feltquate
Executive officer
AL
Andrew Levin
Director
Julie Grant
Director
Emily Minkow
Director
Morgan Haller
Director
Maiken Keson-Brookes
Executive officer